Tandem Diabetes Care (TNDM) Tax Provisions (2018 - 2026)
Tandem Diabetes Care (TNDM) posted Tax Provisions of $500000.0 for Q1 2026, down 90.51% on a QoQ basis from $5.3 million in Q4 2025, and down 94.12% year-over-year from $8.5 million in Q1 2025.
Tandem Diabetes Care (TNDM) Tax Provisions (2018 - 2026) Analysis & Trends
Tandem Diabetes Care's Tax Provisions history runs 9 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- Quarterly Tax Provisions fell 94.12% year-over-year to $500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 137.18% YoY) and the FY2025 annual result came in at $4.4 million, up 6.81% from the prior year.
- Tax Provisions was $500000.0 for Q1 2026 at Tandem Diabetes Care, down from $5.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at $8.5 million in Q1 2025 and bottomed at -$5.3 million in Q2 2025.
- A 5-year average of $776411.8 and a median of $600000.0 in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 2862.96% in 2022, while the deepest fall reached 1600.0% in 2022.
- Tandem Diabetes Care's Tax Provisions stood at -$261000.0 in 2022, then slumped by 414.56% to -$1.3 million in 2023, then jumped by 44.97% to -$739000.0 in 2024, then jumped by 813.26% to $5.3 million in 2025, then plunged by 90.51% to $500000.0 in 2026.
- Business Quant data shows TNDM's Tax Provisions at $500000.0 in Q1 2026, $5.3 million in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 5.27 Mn |
| Sep 30, 2025 | -3.98 Mn |
| Jun 30, 2025 | -5.30 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | -739,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | -261,000.00 |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | -1.70 Mn |
| Dec 31, 2021 | 337,000.00 |
| Sep 30, 2021 | 54,000.00 |
| Jun 30, 2021 | 100,000.00 |